High levels of testosterone inhibit ovarian follicle development by repressing the FSH signaling pathway

Tao Liu , Yu-qian Cui , Han Zhao , Hong-bin Liu , Shi-dou Zhao , Yuan Gao , Xiao-li Mu , Fei Gao , Zi-jiang Chen

Current Medical Science ›› 2015, Vol. 35 ›› Issue (5) : 723 -729.

PDF
Current Medical Science ›› 2015, Vol. 35 ›› Issue (5) : 723 -729. DOI: 10.1007/s11596-015-1497-z
Article

High levels of testosterone inhibit ovarian follicle development by repressing the FSH signaling pathway

Author information +
History +
PDF

Abstract

The effect of high concentrations of testosterone on ovarian follicle development was investigated. Primary follicles and granulosa cells were cultured in vitro in media supplemented with a testosterone concentration gradient. The combined effects of testosterone and follicle-stimulating hormone (FSH) on follicular growth and granulosa cell gonadotropin receptor mRNA expression were also investigated. Follicle growth in the presence of high testosterone concentrations was promoted at early stages (days 1–7), but inhibited at later stage (days 7–14) of in vitro culture. Interestingly, testosterone-induced follicle development arrest was rescued by treatment with high concentrations of FSH (400 mIU/mL). In addition, in cultured granulosa cells, high testosterone concentrations induced cell proliferation, and increased the mRNA expression level of FSH receptor (FSHR), and luteinized hormone/choriogonadotropin receptor. It was concluded that high concentrations of testosterone inhibited follicle development, most likely through regulation of the FSH signaling pathway, although independently from FSHR downregulation. These findings are an important step in further understanding the pathogenesis of polycystic ovary syndrome.

Keywords

testosterone / follicle / follicle-stimulating hormone / polycystic ovary syndrome

Cite this article

Download citation ▾
Tao Liu, Yu-qian Cui, Han Zhao, Hong-bin Liu, Shi-dou Zhao, Yuan Gao, Xiao-li Mu, Fei Gao, Zi-jiang Chen. High levels of testosterone inhibit ovarian follicle development by repressing the FSH signaling pathway. Current Medical Science, 2015, 35(5): 723-729 DOI:10.1007/s11596-015-1497-z

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

LuoW, GumenA, HaughianJM, et al. . The role of luteinizing hormone in regulating gene expression during selection of a dominant follicle in cattle. Biol Reprod, 2011, 84(2): 369-378 PMID: 20962252

[2]

WigglesworthK, LeeKB, O'BrienMJ, et al. . Bidirectional communication between oocytes and ovarian follicular somatic cells is required for meiotic arrest of mammalian oocytes. Proc Natl Acad Sci USA, 2013, 110(39): 3723-3729

[3]

ChengXB, JimenezM, DesaiR, et al. . Characterizing the neuroendocrine and ovarian defects of androgen receptor-knockout female mice. Am J Physiol Endocrinol Metab, 2013, 305(6): 717-726

[4]

HossainMM, CaoM, WangQ, et al. . Altered expression of miRNAs in a dihydrotestosterone-induced rat PCOS model. J Ovarian Res, 2013, 6(1): 36 PMCID: 3682887 PMID: 23675970

[5]

ZhangCP, YangJL, ZhangJ, et al. . Notch signaling is involved in ovarian follicle development by regulating granulosa cell proliferation. Endocrinology, 2011, 152(6): 2437-2447 PMID: 21427220

[6]

KnightPG, GlisterC. Potential local regulatory functions of inhibins, activins and follistatin in the ovary. Reproduction, 2001, 121(4): 503-512 PMID: 11277869

[7]

LenieS, SmitzJ. Functional AR signaling is evident in an in vitro mouse follicle culture bioassay that encompasses most stages of folliculogenesis. Biol Reprod, 2009, 80(4): 685-695 PMID: 19074005

[8]

SánchezF, AdriaenssensT, RomeroS, et al. . Different follicle-stimulating hormone exposure regimens during antral follicle growth alter gene expression in the cumulus-oocyte complex in mice. Biol Reprod, 2010, 83(4): 514-524 PMID: 20592308

[9]

GelmannEP. Molecular biology of the androgen receptor. J Clin Oncol, 2002, 20(13): 3001-3015 PMID: 12089231

[10]

SorokinSP, HoytR f, McNellyNA. Factors influencing fetal macrophage development: I. Reactions of the tumor necrosis factor-alpha cascade and their inhibitors. Anat Rec, 1996, 246(4): 481-497 PMID: 8955788

[11]

StoccoC. Tissue physiology and pathology of aromatase. Steroids, 2012, 77(1–2): 27-35 PMCID: 3286233 PMID: 22108547

[12]

TetsukaM, WhitelawPF, BremnerWJ, et al. . Developmental regulation of androgen receptor in rat ovary. J Endocrinol, 1995, 145(3): 535-543 PMID: 7636438

[13]

HillierSG, TetsukaM. Role of androgens in follicle maturation and atresia. Baillieres Clin Obstet Gynaecol, 1997, 11(2): 249-260 PMID: 9536210

[14]

WeilSJ, VendolaK, ZhouJ, et al. . Androgen receptor gene expression in the primate ovary: cellular localization, regulation, and functional correlations. J Clin Endocrinol Metab, 1998, 83(7): 2479-285 PMID: 9661631

[15]

YangMY, FortuneJE. Testosterone stimulates the primary to secondary follicle transition in bovine follicles in vitro. Biol Reprod, 2006, 75(6): 924-932 PMID: 16943368

[16]

SenA, HammesSR. Granulosa cell-specific androgen receptors are critical regulators of ovarian development and function. Mol Endocrinol, 2010, 24(7): 1393-1403 PMCID: 2903904 PMID: 20501640

[17]

McKennaTJ, LoughlinT, DalyL, et al. . Variable clinical and hormonal manifestations of hyperandrogenemia. Metabolism, 1984, 33(8): 714-717 PMID: 6748943

[18]

LoughlinT, CunninghamSK, CullitonM, et al. . Altered androstenedione and estrone dynamics associated with abnormal hormonal profiles in amenorrheic subjects with weight loss or obesity. Fertil Steril, 1985, 43(5): 720-725 PMID: 3888679

[19]

DunaifA. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev, 1997, 18(6): 774-800 PMID: 9408743

[20]

WaltersKA, AllanCM, HandelsmanDJ. Rodent models for human polycystic ovary syndrome. Biol Reprod, 2012, 86(5): 1-12

[21]

BalenAH, ConwayGS, KaltsasG, et al. . Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients. Hum Reprod, 1995, 6(8): 2107-2111

[22]

WachsDS, CofflerMS, MalcomPJ, et al. . Increased androgen response to follicle-stimulating hormone administration in women with polycystic ovary syndrome. J Clin Endocrinol Metab, 2008, 93(5): 1827-1833 PMCID: 2386684 PMID: 18285408

[23]

TeissierMP, ChableH, PaulhacS, et al. . Comparison of follicle steroidogenesis from normal and polycystic ovaries in women undergoing IVF: relationship between steroid concentrations, follicle size, oocyte quality and fecundability. Hum Reprod, 2000, 15(12): 2471-2477 PMID: 11098013

[24]

JabaraS, CoutifarisC. In vitro fertilization in the PCOS patient: clinical considerations. Semin Reprod Med, 2003, 21(3): 317-324 PMID: 14593555

[25]

CaldwellAS, MiddletonLJ, JimenezM, et al. . Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models. Endocrinology, 2014, 155(8): 3146-3159 PMID: 24877633

[26]

DanielSA, ArmstrongDT. Enhancement of follicle-stimulating hormone-induced aromatase activity by androgens in cultured rat granulosa cells. Endocrinology, 1980, 107(4): 1027-1033 PMID: 6773744

[27]

FulghesuAM, ApaR, BelosiC, et al. . Recombinant versus urinary follicle-stimulating hormone in the low-dose regimen in anovulatory patients with polycystic ovary syndrome: a safer and more effective treatment. Horm Res, 2001, 55(5): 224-228 PMID: 11740143

[28]

AjossaS, GuerrieroS, PaolettiAM, et al. . The treatment of polycystic ovary syndrome. Minerva Ginecol, 2004, 56(1): 15-26 PMID: 14973407

[29]

DudaM, Durlej-GrzesiakM, TabarowskiZ, et al. . Effects of testosterone and 2-hydroxyflutamide on progesterone receptor expression in porcine ovarian follicles in vitro. Reprod Biol, 2012, 12(4): 333-340 PMID: 23229004

[30]

ItamiS, YasudaK, YoshidaY, et al. . Co-culturing of follicles with interstitial cells in collagen gel reproduced follilcular development accompanied with theca cell layer formation. Reprod Biol Endocrinol, 2011, 17(9): 159

[31]

ZhaoKK, CuiYG, JiangYQ, et al. . Effect of HSP10 on apoptosis induced by testosterone in cultured mouse ovarian granulosa cells. Eur J Obstet Gynecol Reprod Biol, 2013, 171(2): 301-306 PMID: 24161766

[32]

AlexandrakiKI, KaltsasGA. Endocrinopathies and other disorders inducing a polycystic ovary syndrome phenotype. Front Horm Res, 2013, 40: 142-157 PMID: 24002411

[33]

LuchettiCG, SolanoME, SanderV, et al. . Effects of dehydroepiandrosterone on ovarian cystogenesis and immune function. J Reprod Immunol, 2004, 64(1–2): 59-74 PMID: 15596227

[34]

SanderV, LuchettiCG, SolanoME, et al. . Role of the N, N'-dimethylbiguanide metformin in the treatment of female prepuberal BALB/c mice hyperandrogenized with dehydroepiandrosterone. Reproduction, 2006, 131(3): 591-602 PMID: 16514202

[35]

BaradDH, GleicherN. Increased oocyte production after treatment with dehydroepiandrosterone. Fertil Steril, 2005, 84(3): 756 PMID: 16169414

[36]

GleicherN, WeghoferA, BaradDH. The role of androgens in follicle maturation and ovulation induction: friend or foe of infertility treatment. Reprod Biol Endocrinol, 2011, 17(9): 116

[37]

WaltersKA, AllanCM, HandelsmanDJ. Androgen actions and the ovary. Biol Reprod, 2008, 78(3): 380-389 PMID: 18003945

[38]

VendolaKA, ZhouJ, AdesanyaOO, et al. . Androgens stimulate early stages of follicular growth in the primate ovary. J Clin Invest, 1998, 101(12): 2622-2629 PMCID: 508852 PMID: 9637695

[39]

PradeepPK, LiX, PeegelH, et al. . Dihydrotestosterone inhibits granulosa cell proliferation by decreasing the cyclin D2 mRNA expression and cell cycle arrest at G1 phase. Endocrinology, 2002, 143(8): 2930-2935 PMID: 12130558

[40]

WangQ, LeaderA, TsangBK. Follicular stage-dependent regulation of apoptosis and steroidogenesis by prohibitin in rat granulosa cells. J Ovarian Res, 2013, 6(1): 23 PMCID: 3635931 PMID: 23567017

[41]

KriplaniA, AgarwalN. Effects of metformin on clinical and biochemical parameters in polycystic ovary syndrome. J Reprod Med, 2004, 49(5): 361-367 PMID: 15214709

[42]

EliaE, SanderV, LuchettiCG, et al. . The mechanisms involved in the action of metformin in regulating ovarian function in hyperandrogenized mice. Mol Hum Reprod, 2006, 12(8): 475-481 PMID: 16809378

[43]

BelgoroskyD, SanderVA, YorioMP, et al. . Hyperandrogenism alters intraovarian parameters during early folliculogenesis in mice. Reprod Biomed Online, 2010, 20(6): 797-807 PMID: 20362510

[44]

GervásioCG, BernuciMP, Silva-de-SáMF, et al. . The role of androgen hormones in early follicular development. ISRN Obstet Gynecol, 2014, 10(2014): 818010

[45]

MersereauJE, EvansML, MooreDH, et al. . Luteal phase estrogen is decreased in regularly menstruating older women compared with a reference population of younger women. Menopause, 2008, 15(3): 482-486 PMID: 18202592

[46]

PassosMJ, VasconcelosGL, SilvaAW, et al. . Accelerated growth of bovine preantral follicles in vitro after stimulation with both FSH and BMP-15 is accompanied by ultrastructural changes and increased atresia. Theriogenology, 2013, 79(9): 1269-1277 PMID: 23582608

[47]

ChavesRN, DuateAB, RodriguesGQ, et al. . The effects of insulin and follicle-simulating hormone (FSH) during in vitro development of ovariangoat preantral follicles and the relative mRNA expression for insulin and FSH receptors and cytochrome P450 aromatase in cultured follicles. Biol Reprod, 2012, 87(3): 69 PMID: 22811569

[48]

ChenZJ, ShiYH, LiY, et al. . Clinical analysis of assistant treatment proposals for infertile women with polycystic ovary syndrome. Zhonghua Fu Chan Ke Za Zhi (Chinese), 2008, 43(8): 571-575

[49]

LaiskT, Haller-KikkataloK, LaanpereM, et al. . Androgen receptor epigenetic variations influence early follicular phase gonadotropin levels. Acta Obstet Gynecol Scand, 2010, 89(12): 1557-1563 PMID: 21050150

[50]

ChenZJ, ZhaoH, HeL, et al. . Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3. Nat Genet, 2011, 43(1): 55-59 PMID: 21151128

AI Summary AI Mindmap
PDF

144

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/